NeuroSense Therapeutics (NRSN) null Earnings

10DecConfirmed
Mar 21
Jun 21
Q2 2021
Dec 21
-0.27
-0.18
-0.09
0

Details

Expected EPS
-0.21
Actual EPS
-0.25
Surprise EPS
-0.04
Surprise Percent
+19.05%

Description

NeuroSense Therapeutics (NRSN) has reported earnings of -0.25 per share for .

0 Comments

Share your thoughts